Andy Peps Studio
Retatrutide
Finnrick tested 11 samples of Retatrutide (GLP-1, GIP, and GCGR agonist) from Andy Peps Studio between 12 Aug 2025 and 19 May 2026. Test scores average over 7, no score below 6, and at least 6 tests warrant a confident Finnrick Rating of A (Great).
Finnrick Rating™
Andy Peps Studio
Retatrutide
Tested 11 Samples
Last test 19 May 2026
Take Action
Free peptide testing
Mail in a sample (US only) to get confidence for the specific vials you have, and contribute to identifying unsafe supply chains, so other people can avoid risky and costly mistakes.
Other Retatrutide tests from top-rated vendors:
All Retatrutide tests from Andy Peps Studio
Samples are tested in commercial labs
Tests Count
11
Scores
AVGMINMAX
Last
19 May 2026
First
12 Aug 2025
| Quantity | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Test Date | Certificate | Test Score | Label | Batch | Tested | Difference | Purity | Endotoxins | Batch ID | Container | Tested At | Sent By |
| 19 May 2026 | View | 30mg | (no batch claim) | 29.1mg | -3.0% | 99.90% | below LOQ | PIQP | No label / Silver crimp / Pink cap | Lab E | Public | |
| 28 Apr 2026 | View | 15mg | (no batch claim) | 15.9mg | +6.0% | 99.90% | n/a | (no batch ID) | No Label / Copper Crimp / Clear Cap | Lab E | Public | |
| 2 Mar 2026 | View | 30mg | (no batch claim) | 30.8mg | +2.7% | 99.90% | low | PIQP | Silver Label / Silver Crimp / Pink Cap | Lab E | Public | |
| 2 Mar 2026 | View | 10mg | (no batch claim) | 9.56mg | -4.4% | 99.90% | n/a | QWPE 12/24/25 | No Label / Silver Crimp / Clear Blue Cap | Lab E | Public | |
| 22 Feb 2026 | View | 20mg | 23.6mg | 22.2mg | -6.0% | 99.90% | low | PIQP | (no data) | Lab E | Public | |
| 18 Feb 2026 | View | 30mg | 34.7mg | 24.7mg | -28.9% | 99.90% | n/a | PIQP | No Label / Silver Crimp / Pink Cap | Lab E | Public | |
| 10 Feb 2026 | View | 10mg | 11.6mg | 11.2mg | -3.6% | 99.70% | n/a | PIPQ | (no data) | Lab G | Public | |
| 4 Feb 2026 | View | 20mg | 23.6mg | 22.4mg | -5.1% | 99.70% | n/a | PIQP | (no data) | Lab G | Public | |
| 2 Feb 2026 | View | 10mg | 11.6mg | 9.49mg | -18.3% | 99.82% | low | PIPQ | (no data) | Lab E | Public | |
| 26 Jan 2026 | View | 30mg | 34.7mg | 30.4mg | -12.5% | 99.80% | n/a | Piqp | No Label / Silver Crimp / Pink Cap | Lab G | Public | |
| 12 Aug 2025 | View | 20mg | 26.9mg | 21.92mg | -18.4% | 99.44% | n/a | R2OZDSH | White Label / Silver Crimp / Yellow Cap | Lab A | Public | |